insights_auto
Outlook: 61.6% bullish·0.0% bearish
Go to analysischevron_right
ABBV:NYSE
AbbVie Common Stock
$285.64
arrow_upward
+0.16%(+0.45) 1D
$285.64
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 23, 4:01:59 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABBV...
Open
$284.58
High
$286.76
Low
$282.30
Mkt. cap
504.76B
Avg. vol.
4.86M
Volume
4.63M
Dividend
2.42%
Quarterly dividend
$1.73
Ex-dividend date
Oct 15, 2026
P/E ratio
80.79
52-wk high
$291.40
52-wk low
$190.75
EPS
$3.54
Beta
0.23
Shares outstanding
1.77B
No. of employees
57K
Open
$284.58
High
$286.76
Low
$282.30
Mkt. cap
504.76B
Avg. vol.
4.86M
Volume
4.63M
Dividend
2.42%
Quarterly dividend
$1.73
Ex-dividend date
Oct 15, 2026
P/E ratio
80.79
52-wk high
$291.40
52-wk low
$190.75
EPS
$3.54
Beta
0.23
Shares outstanding
1.77B
No. of employees
57K
News stories
From web sources and news partners
Investing.com Nigeria
·
2 hours ago
FDA approves subcutaneous induction regimen for AbbVie’s Skyrizi By Investing.com
Investing.com
·
8 hours ago
AbbVie shares may move 5% on Oct. 30 earnings release
Yahoo Finance
·
8 hours ago
BMY vs. ABBV: Which Pharma/Biotech Stock Offers More Upside Potential?
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com